As of 2026-09-20, the Relative Valuation of Homology Medicines Inc (FIXX) is (1,006.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.04 USD, the upside of Homology Medicines Inc based on Relative Valuation is -7821.9%.
The range of the Relative Valuation is (928.73) - (1,163.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 23.8x | 21.4x |
| Forward P/E multiples | 15.7x - 23.9x | 19.8x |
| Fair Price | (928.73) - (1,163.35) | (1,006.94) |
| Upside | -7222.1% - -9021.4% | -7821.9% |
| Date | P/E |
| 2026-09-18 | -0.27 |
| 2026-09-17 | -0.24 |
| 2026-09-16 | -0.25 |
| 2026-09-15 | -0.24 |
| 2026-09-14 | -0.25 |
| 2026-09-11 | -0.28 |
| 2026-09-10 | -0.25 |
| 2026-09-09 | -0.26 |
| 2026-09-08 | -0.27 |
| 2026-09-04 | -0.26 |
| 2026-09-03 | -0.25 |
| 2026-09-02 | -0.24 |
| 2026-09-01 | -0.24 |
| 2026-08-31 | -0.24 |
| 2026-08-28 | -0.23 |
| 2026-08-27 | -0.26 |
| 2026-08-26 | -0.26 |
| 2026-08-25 | -0.25 |
| 2026-08-24 | -0.26 |
| 2026-08-21 | -0.28 |
| 2026-08-20 | -0.28 |
| 2026-08-19 | -0.29 |